Is biontech a good stock to buy?

The company's average rating score is 2.42, and is based on 5 buy ratings, 7 hold ratings, and no sell ratings. According to analysts' consensus price target of $160.29, BioNTech has a forecasted upside of 63.4% from its current price of $98.12. BioNTech has only been the subject of 3 research reports in the past 90 days.

How much does biontech (ADRs) stock cost?

On Monday morning 08/21/2023 the BioNTech (ADRs) share started trading at the price of $111.36. Compared to the closing price on Friday 08/18/2023 on NAS of $110.36, this is a gain of 0.91%. There are 239.77 M shares outstanding in BioNTech (ADRs), which values the company at $27.21 B. Why did BioNTech stock go up today?

Where is biontech SE based?

The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany. The Fool has written over 300 articles on BioNTech Se. While the waning of the COVID pandemic is a positive development for the world, it's left the German biotech struggling.

How much did biontech se earn in a quarter?

BioNTech SE (NASDAQ:BNTX) released its quarterly earnings data on Monday, May, 8th. The company reported $2.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $1.87. The business earned $1.28 billion during the quarter, compared to analyst estimates of $1.09 billion.